Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Total Current Assets: ¥1,404 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:605016 Shandong Bailong Chuangyuan Bio-Tech Co Ltd SHSE:605016
96 GF Score
Price ¥21.50
GF Value ¥22.57
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Shandong Bailong Chuangyuan Bio-Tech Co Total Current Assets?

Shandong Bailong Chuangyuan Bio-Tech Co SHSE:605016 -9.24% 96 Total Current Assets is ¥1,404 Mil as of Mar. 2026. GuruFocus rates SHSE:605016 with a GF Score™ of 96/100 and a GF Value™ of ¥22.57 (Fairly Valued). The stock has 3 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Shandong Bailong Chuangyuan Bio-Tech Co's total current assets for the quarter that ended in Mar. 2026 was ¥1,404 Mil.


Shandong Bailong Chuangyuan Bio-Tech Co  (SHSE:605016) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Shandong Bailong Chuangyuan Bio-Tech Co's Liquidation Value for the quarter that ended in Mar. 2026 is

Liquidation value
= Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=701.948-717.553+0.75 * 344.001+0.5 * 302.541
=394

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Bailong Chuangyuan Bio-Tech Co Total Current Assets Related Terms


Shandong Bailong Chuangyuan Bio-Tech Co Total Current Assets Historical Data

* Premium members only.

The historical data trend for Shandong Bailong Chuangyuan Bio-Tech Co's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Bailong Chuangyuan Bio-Tech Co Total Current Assets Chart

Shandong Bailong Chuangyuan Bio-Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 831.89 855.54 773.74 901.46 1,135.17

Shandong Bailong Chuangyuan Bio-Tech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,050.76 1,119.12 1,292.21 1,135.17 1,403.63
SHSE:605016
96GF Score
Shandong Bailong Chuangyuan Bio-Tech Co Ltd SHSE:605016
Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Bailong Chuangyuan Bio-Tech Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Shandong Bailong Chuangyuan Bio-Tech Co's Total Current Assets for the fiscal year that ended in Dec. 2025 is calculated as

Shandong Bailong Chuangyuan Bio-Tech Co's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →
What does a Total Current Assets of ¥1,404 Mil mean?
Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) has a Total Current Assets of ¥1,404 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Shandong Bailong Chuangyuan Bio-Tech Co and its competitors.
Is Shandong Bailong Chuangyuan Bio-Tech Co's Total Current Assets too high?
Shandong Bailong Chuangyuan Bio-Tech Co's current Total Current Assets is ¥1,404 Mil. Overall, Shandong Bailong Chuangyuan Bio-Tech Co has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shandong Bailong Chuangyuan Bio-Tech Co's Total Current Assets compare to KHC and GIS?
Shandong Bailong Chuangyuan Bio-Tech Co's Total Current Assets of ¥1,404 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Consumer Packaged Goods company?
A good Total Current Assets depends on the Consumer Packaged Goods industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for Shandong Bailong Chuangyuan Bio-Tech Co and its competitors. Shandong Bailong Chuangyuan Bio-Tech Co's current Total Current Assets is ¥1,404 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Bailong Chuangyuan Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) is currently considered Fairly Valued. The stock's GF Value™ is ¥22.57, compared to a current price of ¥21.50 — trading 4.7% below its estimated fair value. The current Total Current Assets is ¥1,404 Mil. Shandong Bailong Chuangyuan Bio-Tech Co's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016), the current Total Current Assets is ¥1,404 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Bailong Chuangyuan Bio-Tech Co stock appears to be undervalued. The current stock price of ¥21.50 is trading 4.7% below its estimated GF Value™ of ¥22.57. GuruFocus considers Shandong Bailong Chuangyuan Bio-Tech Co to be Fairly Valued.

Key valuation signals for SHSE:605016:

  • Total Current Assets: ¥1,404 Mil
  • GF Value™: ¥22.57 vs. price of ¥21.50 (4.7% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the SHSE:605016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Bailong Chuangyuan Bio-Tech Co Business Description

Address Dexin Street, National High-tech Industrial Development Zone, Yucheng, Shandong Province, Dezhou, CHN, 251200
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
96GF Score

Get the complete analysis for SHSE:605016

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥21.50
Price
¥22.57
GF Value